Search

Search


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Search results for {{term}}

111. Community Lab

The following equipment can be found in SBC's Community zone and is accessible, free of charge, by lab-based tenants: Autoclave Dishwasher -80oC Freezer plus back-up -80oCfreezer Cold room Water purification unit (ELGA) Ice machine Large volume centrifuge (Beckman) Ultracentrifuge (Sorvall) Real time PCR (BioRad CFX Connect) Thermal Cycler (G Storm 4-position) Thermal Cycler (Techne 1-position) GE Nanovue spectrophotomer Thermo multidrop spectrophotometer Carey Spectrophotometer A


112. Summit Announces Further US Patent Granted for CDI Antibiotic Ridinila

Summit Announces Further US Patent Granted for CDI Antibiotic Ridinilazole 28/04/2016Oxford, UK – Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and Ridinilazole is a novel class antibiotic with potential for broad use in the treatment of CDI. In a Phase 2 clinical trial, ridinilazole showed statistical superiority over vancomycin in rates of sustained


113. Bevespi Aerosphere Approved by the US FDA for Patients with COPD

Bevespi Aerosphere Approved by the US FDA for Patients with COPD 25/04/2016AstraZeneca today announced that the US Food and Drug Administration has approved Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) inhalation aerosol indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.Sean Bohen, Executive Vice-President, Global Medicines Development and Chief


114. UBS Raises Record $471m for Oncology Impact Fund". Zurich & Basel.

UBS Raises Record $471m for Oncology Impact Fund". Zurich & Basel. 27/04/2016World’s largest global wealth manager concludes fundraising for innovative impact investing fund aimed at developing cancer treatmentsUBS Wealth Management has raised a record $471 million for the final closing of the UBS Oncology Impact Fund, an impact investing initiative aimed at developing cancer treatments.Investments will be made in early stage oncology to accelerate the development of new cures. Ca


115. BTG plc Acquires Galil Medical, a Leader in Cryoablation

BTG plc Acquires Galil Medical, a Leader in Cryoablation 06/05/2016Builds on BTG’s leadership in Interventional Oncology, expanding franchise into attractive and complementary ablation marketGalil Medical is a leader in cryoablation of kidney cancer with significant pipeline opportunities including lung cancerBTG plc (LSE: BTG), the specialist healthcare company, today announces that it has entered into an agreement to acquire Galil Medical, a leading provider of cryoablation products



Page 23 of 44 ( 219 results in total )
© Catalyst Innovation Portal 2019